RxDoctor Payments Data

Mohammad Jamil, MD

Internal Medicine · Peoria, AZNPI 1255419206

Payments from drug & device makers

$1,547in general payments, 2019–2025

Across 47 payments — averaging $32.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$183
  • AstraZeneca$173
  • Amgen$166
  • Biotronik Inc.$148
  • Inari Medical, Inc.$138
  • Medtronic$138
  • plus $601 from 17 others

What the payments were for

  • Travel & lodging$18312%
  • Food & beverage$1,36488%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,547 in reported general payments places this provider in the 80th percentile of 2,212 internal medicine providers in Arizona.

See all internal medicine providers in Arizona

Medicare billing

Part B allowed, 2024
$187,037
Medicare patients
447
Services billed
1,779

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban42$52,836
TrulicityDulaglutide37$43,347
OzempicSemaglutide16$22,992
JanuviaSitagliptin Phosphate24$19,145
MounjaroTirzepatide16$16,428
Trokendi XrTopiramate11$16,330
JardianceEmpagliflozin11$10,633
TradjentaLinagliptin15$10,250
BrilintaTicagrelor14$9,615
Atorvastatin Calcium315$2,847
Levothyroxine Sodium204$2,521
Gabapentin97$2,258
Albuterol Sulfate HfaAlbuterol Sulfate71$2,160
Potassium Chloride67$2,159
LantusInsulin Glargine,hum.Rec.Anlog21$2,127

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$15$59,77553 claims
Novo NordiskOzempic$33$22,99216 claims
AstraZenecaBrilinta$173$9,61514 claims
Sanofi-aventis U.S. LLCLantus$55$2,12721 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,212 internal medicine providers in Arizona.

Other internal medicine in Peoria

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →